Skip to main content
Premium Trial:

Request an Annual Quote

Benitec Sues Nucleonics, Ambion, Genscript over RNAi Patent

NEW YORK, March 26 (GenomeWeb News) - Benitec is suing Nucleonics, Ambion, and Genscript in the US for infringing its patent on RNAi technology, the Australian company said yesterday.

 

Benitec, of Queensland, has filed suits in the US District Court for the District of Delaware, alleging that the three companies are infringing its US Patent No. 6,573,099, entitled "Genetic Constructs for Delaying or Repressing the Expression of a Target Gene." The patent covers DNA-directed RNA interference.

 

According to Benitec's chairman and CEO, John McKinley, "Benitec will consider additional infringement actions as we deem appropriate in other jurisdictions."

The Scan

Gain of Oversight

According to the Wall Street Journal, the Biden Administration is considering greater oversight of gain-of-function research.

Lasker for mRNA Vaccine Work

The Scientist reports that researchers whose work enabled the development of mRNA-based vaccines are among this year's Lasker Award winners

PLOS Papers on Causal Variant Mapping, Ancient Salmonella, ALK Fusion Test for NSCLC

In PLOS this week: MsCAVIAR approach to map causal variants, analysis of ancient Salmonella, and more.

US Booster Eligibility Decision

The US CDC director recommends that people at high risk of developing COVID-19 due to their jobs also be eligible for COVID-19 boosters, in addition to those 65 years old and older or with underlying medical conditions.